China Reins In Cancer Drug Trials, Stressing Patient Needs and Benefits

Tougher Comparator Requirements

 
• By Dexter Jie Yan
  
clinical trial progress
China’s CDE stipulates clinical value is determined by whether clinical needs can be met to maximize patients’ benefits • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia